Argenica Therapeutics LtdASX: AGN

Phase 2 Stroke Clinical Trial Update

Dec 10, 2024 at 4:19 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment